(Q51712244)

10 April 2018

editorial

0 references

title

Pro: mice are a good model of human airway disease. (English)

1 reference

10 April 2018

1

Erwin W Gelfand

1 reference

10 April 2018

language of work or name

English

0 references

publication date

1 July 2002

1 reference

10 April 2018

American Journal of Respiratory and Critical Care Medicine

published in

1 reference

10 April 2018

volume

166

1 reference

10 April 2018

issue

1

1 reference

10 April 2018

page(s)

5-6; discussion 7-8

1 reference

10 April 2018

Immunologic basis of antigen-induced airway hyperresponsiveness

cites work

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2204023

Development of eosinophilic airway inflammation and airway hyperresponsiveness in mast cell-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2204023

The late, but not early, asthmatic response is dependent on IL-5 and correlates with eosinophil infiltration

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2204023

A role for cysteinyl leukotrienes in airway remodeling in a mouse asthma model

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2204023

Degranulation patterns of eosinophil granulocytes as determinants of eosinophil driven disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2204023

Extensive eosinophil degranulation and peroxidase-mediated oxidation of airway proteins do not occur in a mouse ovalbumin-challenge model of pulmonary inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2204023

Allergic networks regulating eosinophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2204023

Pulmonary T cells and eosinophils: coconspirators or independent triggers of allergic respiratory pathology?

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2204023

Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2204023

The trials and tribulations of IL-5, eosinophils, and allergic asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2204023

Inhibition of phosphodiesterase 4 attenuates airway hyperresponsiveness and airway inflammation in a model of secondary allergen challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2204023

Therapeutic strategies for allergic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2204023

The failure of interleukin-10-deficient mice to develop airway hyperresponsiveness is overcome by respiratory syncytial virus infection in allergen-sensitized/challenged mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2204023

21 January 2018

Identifiers

DOI

10.1164/RCCM.2204023

1 reference

10 April 2018

PubMed ID

12091160

1 reference

10 April 2018